Leunis, Annemieke; Redekop, W.; Montfort, Kees van; … - In: PharmacoEconomics 31 (2013) 7, pp. 605-621
The model developed in this study is proved to be valid for analysis of an AML population participating in a clinical trial. The generalizability of the model to a broader patient population has not been proven yet. Further research is needed to identify differences between the clinical trial...